Clinical Trials
11 trialsNCT00033371 2020-09-29
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT00099047 2016-12-30
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006381 2013-12-19
Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00589186 2013-12-18
Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00023621 2013-06-26
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
National Cancer Institute (NCI)
Phase 2 Completed
NCT00043043 2013-06-19
Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00062101 2013-06-06
Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00025051 2013-03-22
Celecoxib in Preventing Skin Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00072553 2009-02-09
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00274898 2009-02-09
Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00001955 2008-03-04
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed